Need help with your APIs? I offer API discovery, governance & evangelism services. Explore services →
API Evangelist API Evangelist
Discovery
Learnings
Guidance
Toolbox
Alignment
API Evangelist LLC
Shanghai Desano Pharmaceutical Group website screenshot

Shanghai Desano Pharmaceutical Group

Shanghai Desano Pharmaceutical Group Co., Ltd. is a Chinese pharmaceutical company established in 1996 and headquartered in Shanghai's Zhangjiang High-Tech Park. It develops and commercializes medications addressing global public health needs, specializing in anti-AIDS (antiretroviral) and anti-malaria drugs, steroid hormone drugs, and nucleic acid drugs, with operations spanning R&D, manufacturing, regulatory registration, and international distribution across multiple production bases in Shanghai, Jiangsu, and Jiangxi. Note: in this company's domain "API" means Active Pharmaceutical Ingredient (drug chemistry), not a web/developer API. Desano publishes no developer API, OpenAPI, SDK, developer portal, or other machine-readable API surface, so the API Evangelist enrichment pipeline has no technical artifacts to produce for this provider. It was surfaced as a false-positive lead from the Qiming venture portfolio.

human only

Index entry only — little beyond a description and a link, and nothing machine-readable enough for an agent to act on without a human reading the site first.

Kin Score

Shanghai Desano Pharmaceutical Group is tracked in the API Evangelist network. This page is the human-readable profile that sits on top of the machine-readable index we maintain at apis.io.

Every provider in the network is reduced to the same set of machine-readable artifacts — OpenAPI contracts, event specifications, GraphQL schemas, runnable collections, pricing and rate-limit signals, security posture, OAuth scopes, and the agent surfaces (MCP servers and skills) that let software drive the API on its own. We profile them because the interface is the part of a company you can actually inspect: it is a truer signal of what a provider does than any marketing page. From those artifacts we compute the Kin Score — Shanghai Desano Pharmaceutical Group scores 5.7/100 (minimal), with a separate agent-readiness read of 0/100 (human only). The full breakdown is below, followed by every artifact we hold — each card links through to its machine-readable definition on apis.io.

Kin Score

This is the API Evangelist rating — a single, repeatable read computed from the artifacts on this page. Green fill is points earned; the red track is points possible, so every bar shows earned-versus-possible at a glance.

Kin Score Kin Score How this is scored →
scored 2026-07-27 · rubric v0.5
Composite quality — 5.7/100 · minimal
Contract Quality 0.0 / 25
Developer Ergonomics 0.0 / 20
Commercial Clarity 0.0 / 20
Operational Transparency 0.0 / 13
Governance 0.0 / 12
Discoverability 6.8 / 10
Regulatory · Health 0.0 / 15
Agent readiness — 0/100 · human only
Machine-Readable Contract 0 / 18
Agentic Access Contract 0 / 15
MCP Server 0 / 12
Machine-Readable Auth 0 / 10
Idempotency 0 / 9
Stable Error Semantics 0 / 8
Request/Response Examples 0 / 7
Rate-Limit Signaling 0 / 7
Typed Event Surface 0 / 6
Agent Skills 0 / 5
Well-Known Catalog 0 / 4
Consent & Bot Identity 0 / 3

Resources

Every other property we hold for Shanghai Desano Pharmaceutical Group — documentation, portals, status pages, policies, and corporate surface — grouped by the job it does, following the integrator's arc from getting started to running in production.

Company 1

The organization behind the API

Shanghai Desano Pharmaceutical Group is in the network as a tracked entity. We haven't yet indexed a public API surface for it — when one is published, the artifacts, score, and agent-readiness read will appear here automatically. The source repository is where that profile is built.

← All providers · Data indexed from github.com/api-evangelist/desano · machine-readable index on apis.io